Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

OBJECTIVE: This placebo-controlled study assessed long-term efficacy and safety of the dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes and severe renal impairment (RI). RESEARCH DESIGN AND METHODS: In this 1-year, double-blind study, 133 patients with type 2 diabetes (H...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: McGill, Janet B., Sloan, Lance, Newman, Jennifer, Patel, Sanjay, Sauce, Christophe, von Eynatten, Maximilian, Woerle, Hans-Juergen
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Diabetes Association 2013
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3554278/
https://ncbi.nlm.nih.gov/pubmed/23033241
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc12-0706
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak